22
Participants
Start Date
November 1, 2023
Primary Completion Date
April 16, 2024
Study Completion Date
April 29, 2024
Vonoprazan
Administered orally
Advantage Clinical Trials, The Bronx
Children's Center for Digestive Health Care, LLC, Atlanta
Avanza Medical Research Center, Pensacola
Med Research Associates, Inc, Hollywood
International Center for Research, Tampa
Strada Patient Care Center, Mobile
PriMED Clinical Research, Dayton
Riley Hospital for Children at IU Health, Indianapolis
Tandem Clinical Research GI, LLC, Marrero
Preferred Research Partners, Inc., Little Rock
Stryde Research - NxT Step Pediatrics, Frisco
Maspons Pediatric Gastro, El Paso
Cyn3rgy Research, Gresham
Lead Sponsor
Phathom Pharmaceuticals, Inc.
INDUSTRY